Epigenetic regulation of Nanog expression by Ezh2 in pluripotent stem cells
- PMID: 21490431
- PMCID: PMC3615336
- DOI: 10.4161/cc.10.9.15658
Epigenetic regulation of Nanog expression by Ezh2 in pluripotent stem cells
Abstract
Nanog levels in pluripotent stem cells are heterogeneous and this is thought to reflect two different and interchangeable cell states, respectively poised to self-renew (Nanog-high subpopulation) or to differentiate (Nanog-low subpopulation). However, little is known about the mechanisms responsible for this pattern of Nanog expression. Here, we have examined the impact of the histone methyltransferase Ezh2 on pluripotent stem cells and on Nanog expression. Interestingly, induced pluripotent stem (iPS) cells lacking Ezh2 presented higher levels of Nanog due to a relative expansion of the Nanog-high subpopulation, and this was associated to severe defects in differentiation. Moreover, we found that the Nanog promoter in embryonic stem (ES) cells and iPS cells coexists in two alternative univalent chromatin configurations, either H3K4me3 or H3K27me3, the latter being dependent on the presence of functional Ezh2. Finally, the levels of expression of Ezh2, as well as the amount of H3K27me3 present at the Nanog promoter, were higher in the Nanog-low subpopulation of ES/iPS cells. Together, these data indicate that Ezh2 directly regulates the epigenetic status of the Nanog promoter affecting the balance of Nanog expression in pluripotent stem cells and, therefore, the equilibrium between self-renewal and differentiation.
Figures
Comment in
-
Epigenetic Nanog regulation and the role of functional heterogeneity.Cell Cycle. 2011 Jul 15;10(14):2252-3. doi: 10.4161/cc.10.14.16203. Epub 2011 Jul 15. Cell Cycle. 2011. PMID: 21670592 No abstract available.
-
An Ezh way to turn off Nanog.Cell Cycle. 2011 Jul 15;10(14):2253-4. doi: 10.4161/cc.10.14.16388. Epub 2011 Jul 15. Cell Cycle. 2011. PMID: 21670594 No abstract available.
Similar articles
-
Global gene expression analysis of very small embryonic-like stem cells reveals that the Ezh2-dependent bivalent domain mechanism contributes to their pluripotent state.Stem Cells Dev. 2012 Jul 1;21(10):1639-52. doi: 10.1089/scd.2011.0389. Epub 2012 Jan 4. Stem Cells Dev. 2012. PMID: 22023227 Free PMC article.
-
Chromatin changes in dicer-deficient mouse embryonic stem cells in response to retinoic acid induced differentiation.PLoS One. 2013 Sep 9;8(9):e74556. doi: 10.1371/journal.pone.0074556. eCollection 2013. PLoS One. 2013. PMID: 24040281 Free PMC article.
-
Polycomb repressive complex 2 regulates normal development of the mouse heart.Circ Res. 2012 Feb 3;110(3):406-15. doi: 10.1161/CIRCRESAHA.111.252205. Epub 2011 Dec 8. Circ Res. 2012. PMID: 22158708 Free PMC article.
-
Pluripotency and Epigenetic Factors in Mouse Embryonic Stem Cell Fate Regulation.Mol Cell Biol. 2015 Aug;35(16):2716-28. doi: 10.1128/MCB.00266-15. Epub 2015 Jun 1. Mol Cell Biol. 2015. PMID: 26031336 Free PMC article. Review.
-
Nanog and transcriptional networks in embryonic stem cell pluripotency.Cell Res. 2007 Jan;17(1):42-9. doi: 10.1038/sj.cr.7310125. Cell Res. 2007. PMID: 17211451 Review.
Cited by
-
FOXC1 Downregulates Nanog Expression by Recruiting HDAC2 to Its Promoter in F9 Cells Treated by Retinoic Acid.Int J Mol Sci. 2021 Feb 24;22(5):2255. doi: 10.3390/ijms22052255. Int J Mol Sci. 2021. PMID: 33668324 Free PMC article.
-
Vascularized Tissue-Engineered Model for Studying Drug Resistance in Neuroblastoma.Theranostics. 2017 Sep 21;7(17):4099-4117. doi: 10.7150/thno.20730. eCollection 2017. Theranostics. 2017. PMID: 29158813 Free PMC article.
-
Nono, a Bivalent Domain Factor, Regulates Erk Signaling and Mouse Embryonic Stem Cell Pluripotency.Cell Rep. 2016 Oct 18;17(4):997-1007. doi: 10.1016/j.celrep.2016.09.078. Cell Rep. 2016. PMID: 27760330 Free PMC article.
-
Current status in cancer cell reprogramming and its clinical implications.J Cancer Res Clin Oncol. 2017 Mar;143(3):371-383. doi: 10.1007/s00432-016-2258-5. Epub 2016 Sep 12. J Cancer Res Clin Oncol. 2017. PMID: 27620745 Review.
-
Epigenetic Research in Stem Cell Bioengineering-Anti-Cancer Therapy, Regenerative and Reconstructive Medicine in Human Clinical Trials.Cancers (Basel). 2020 Apr 21;12(4):1016. doi: 10.3390/cancers12041016. Cancers (Basel). 2020. PMID: 32326172 Free PMC article. Review.
References
-
- Bracken AP, Helin K. Polycomb group proteins: navigators of lineage pathways led astray in cancer. Nat Rev Cancer. 2009;9:773–84. - PubMed
-
- Montgomery ND, Yee D, Chen A, Kalantry S, Chamberlain SJ, Otte AP, et al. The murine polycomb group protein Eed is required for global histone H3 lysine-27 methylation. Curr Biol. 2005;15:942–7. - PubMed
-
- Boyer LA, Plath K, Zeitlinger J, Brambrink T, Medeiros LA, Lee TI, et al. Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature. 2006;441:349–53. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials